Regeneron Pharmaceuticals
REGN
REGN
511 hedge funds and large institutions have $29.5B invested in Regeneron Pharmaceuticals in 2014 Q4 according to their latest regulatory filings, with 87 funds opening new positions, 173 increasing their positions, 189 reducing their positions, and 43 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
8% less repeat investments, than reductions
Existing positions increased: 173 | Existing positions reduced: 189
26% less call options, than puts
Call options by funds: $588M | Put options by funds: $790M
Holders
511
Holding in Top 10
19
Calls
$588M
Puts
$790M
Top Buyers
| 1 | +$295M | |
| 2 | +$279M | |
| 3 | +$201M | |
| 4 |
American Century Companies
Kansas City,
Missouri
|
+$111M |
| 5 |
JPMorgan Chase & Co
New York
|
+$89.6M |
Top Sellers
| 1 | -$390M | |
| 2 | -$227M | |
| 3 | -$84.2M | |
| 4 |
Wells Fargo
San Francisco,
California
|
-$82.1M |
| 5 |
UBS AM
Chicago,
Illinois
|
-$67.1M |